Global Irbesartan Tablets Market Insights, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 111

Report ID: 19227

Irbesartan is an oral medication that is used to treat high blood pressure (hypertension) and diabetic nephropathy or kidney disease. It belongs to a class of drugs called angiotensin receptor blockers (ARBs).
The global Irbesartan Tablets market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Irbesartan Tablets market based on company, product type, end user and key regions.

This report studies the global market size of Irbesartan Tablets in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Irbesartan Tablets in these regions.
This research report categorizes the global Irbesartan Tablets market by top players/brands, region, type and end user. This report also studies the global Irbesartan Tablets market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva
Sanofi
Taj Pharmaceuticals
Apotex
Jiangsu Hengrui Medicine
Zhuhai Rundu Pharmaceutica
Verdant Life Sciences

Irbesartan Tablets market size by Type
75 mg Tablets
150 mg Tablets
300 mg Tablets
Irbesartan Tablets market size by Applications
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Irbesartan Tablets market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Irbesartan Tablets market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Irbesartan Tablets companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Irbesartan Tablets submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Irbesartan Tablets are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Irbesartan Tablets market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Irbesartan Tablets Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Irbesartan Tablets Market Size Growth Rate by Type
1.4.2 75 mg Tablets
1.4.3 150 mg Tablets
1.4.4 300 mg Tablets
1.5 Market by Application
1.5.1 Global Irbesartan Tablets Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Irbesartan Tablets Market Size
2.1.1 Global Irbesartan Tablets Revenue 2014-2025
2.1.2 Global Irbesartan Tablets Sales 2014-2025
2.2 Irbesartan Tablets Growth Rate by Regions
2.2.1 Global Irbesartan Tablets Sales by Regions
2.2.2 Global Irbesartan Tablets Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Irbesartan Tablets Sales by Manufacturers
3.1.1 Irbesartan Tablets Sales by Manufacturers
3.1.2 Irbesartan Tablets Sales Market Share by Manufacturers
3.2 Irbesartan Tablets Revenue by Manufacturers
3.2.1 Irbesartan Tablets Revenue by Manufacturers (2014-2019)
3.2.2 Irbesartan Tablets Revenue Share by Manufacturers (2014-2019)
3.3 Irbesartan Tablets Price by Manufacturers
3.4 Irbesartan Tablets Manufacturing Base Distribution, Product Types
3.4.1 Irbesartan Tablets Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Irbesartan Tablets Product Type
3.4.3 Date of International Manufacturers Enter into Irbesartan Tablets Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Irbesartan Tablets Sales by Type
4.2 Global Irbesartan Tablets Revenue by Type
4.3 Irbesartan Tablets Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Irbesartan Tablets Breakdown Data by Application

6 North America
6.1 North America Irbesartan Tablets by Country
6.1.1 North America Irbesartan Tablets Sales by Country
6.1.2 North America Irbesartan Tablets Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Irbesartan Tablets by Type
6.3 North America Irbesartan Tablets by Application

7 Europe
7.1 Europe Irbesartan Tablets by Country
7.1.1 Europe Irbesartan Tablets Sales by Country
7.1.2 Europe Irbesartan Tablets Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Irbesartan Tablets by Type
7.3 Europe Irbesartan Tablets by Application

8 Asia Pacific
8.1 Asia Pacific Irbesartan Tablets by Country
8.1.1 Asia Pacific Irbesartan Tablets Sales by Country
8.1.2 Asia Pacific Irbesartan Tablets Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Irbesartan Tablets by Type
8.3 Asia Pacific Irbesartan Tablets by Application

9 Central & South America
9.1 Central & South America Irbesartan Tablets by Country
9.1.1 Central & South America Irbesartan Tablets Sales by Country
9.1.2 Central & South America Irbesartan Tablets Revenue by Country
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Irbesartan Tablets by Type
9.3 Central & South America Irbesartan Tablets by Application

10 Middle East and Africa
10.1 Middle East and Africa Irbesartan Tablets by Country
10.1.1 Middle East and Africa Irbesartan Tablets Sales by Country
10.1.2 Middle East and Africa Irbesartan Tablets Revenue by Country
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Irbesartan Tablets by Type
10.3 Middle East and Africa Irbesartan Tablets by Application

11 Company Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Company Business Overview
11.1.3 Teva Irbesartan Tablets Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Teva Irbesartan Tablets Products Offered
11.1.5 Teva Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Irbesartan Tablets Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Irbesartan Tablets Products Offered
11.2.5 Sanofi Recent Development
11.3 Taj Pharmaceuticals
11.3.1 Taj Pharmaceuticals Company Details
11.3.2 Company Business Overview
11.3.3 Taj Pharmaceuticals Irbesartan Tablets Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Taj Pharmaceuticals Irbesartan Tablets Products Offered
11.3.5 Taj Pharmaceuticals Recent Development
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Company Business Overview
11.4.3 Apotex Irbesartan Tablets Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Apotex Irbesartan Tablets Products Offered
11.4.5 Apotex Recent Development
11.5 Jiangsu Hengrui Medicine
11.5.1 Jiangsu Hengrui Medicine Company Details
11.5.2 Company Business Overview
11.5.3 Jiangsu Hengrui Medicine Irbesartan Tablets Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Jiangsu Hengrui Medicine Irbesartan Tablets Products Offered
11.5.5 Jiangsu Hengrui Medicine Recent Development
11.6 Zhuhai Rundu Pharmaceutica
11.6.1 Zhuhai Rundu Pharmaceutica Company Details
11.6.2 Company Business Overview
11.6.3 Zhuhai Rundu Pharmaceutica Irbesartan Tablets Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Zhuhai Rundu Pharmaceutica Irbesartan Tablets Products Offered
11.6.5 Zhuhai Rundu Pharmaceutica Recent Development
11.7 Verdant Life Sciences
11.7.1 Verdant Life Sciences Company Details
11.7.2 Company Business Overview
11.7.3 Verdant Life Sciences Irbesartan Tablets Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Verdant Life Sciences Irbesartan Tablets Products Offered
11.7.5 Verdant Life Sciences Recent Development

12 Future Forecast
12.1 Irbesartan Tablets Market Forecast by Regions
12.1.1 Global Irbesartan Tablets Sales Forecast by Regions 2019-2025
12.1.2 Global Irbesartan Tablets Revenue Forecast by Regions 2019-2025
12.2 Irbesartan Tablets Market Forecast by Type
12.2.1 Global Irbesartan Tablets Sales Forecast by Type 2019-2025
12.2.2 Global Irbesartan Tablets Revenue Forecast by Type 2019-2025
12.3 Irbesartan Tablets Market Forecast by Application
12.4 North America Irbesartan Tablets Forecast
12.5 Europe Irbesartan Tablets Forecast
12.6 Asia Pacific Irbesartan Tablets Forecast
12.7 Central & South America Irbesartan Tablets Forecast
12.8 Middle East and Africa Irbesartan Tablets Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Irbesartan Tablets Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer